I agree that this site is using cookies. You can find further informations here.
X
Acar, Ibrahim Halil
342  results:
Search for persons X
?
1

Therapeutic plasma exchange in critically ill children: 18-..:

Ekinci, Faruk ; Yildizdas, Dincer ; Horoz, Ozden Ozgur...
Australian Critical Care.  37 (2024)  4 - p. 592-599 , 2024
Link: https://doi.org/10.1016/..
 
?
2

RİCHTER SYNDROME TRANSFORMATİON UNDER VENETOCLAX TREATMENT:..:

Açar, İbrahim Halil ; Güvenç, Birol
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S33-S34 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Long-Term Efficacy of Erythropoiesis-Stimulating Agents in ..:

Aslaner Ak, Müzeyyen ; Gedük, Ayfer ; Acar, İbrahim Halil...
Turkish Journal of Hematology.  40 (2023)  2 - p. 92-100 , 2023
Link: https://doi.org/10.4274/..
 
?
4

MPN-238 Evaluating the Efficacy of Therapeutic Plasma Excha..:

Açar, İbrahim Halil ; Güvenç, Birol
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S388 , 2023
Link: https://doi.org/10.1016/..
 
?
5

UNUSUAL PRESENTATİON OF RHABDOMYOSARCOMA WİTH BONE MARROW I..:

Açar, Nuray Gül ; Açar, İbrahim Halil ; Şahin, Berksoy.
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S20-S21 , 2023
Link: https://doi.org/10.1016/..
 
?
6

UNRAVELING BLOOD DONOR DEFERRAL TRENDS: A REAL-WORLD SINGLE..:

Açar, İbrahim Halil ; Yıldız, Şule Menziletoğu ; Güvenç, Birol
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S42 , 2023
Link: https://doi.org/10.1016/..
 
?
7

IBRUTİNİB-OBİNUTUZUMAB COMBİNATİON THERAPY İN THE TREATMENT..:

Açar, Nuray Gül ; Açar, İbrahim Halil ; Güvenç, Birol
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S14 , 2023
Link: https://doi.org/10.1016/..
 
?
8

POSTER: CLL-237 Efficacy of Cladribine Combine With Rituxim..:

Açar, İbrahim Halil ; Güvenç, Birol
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S172 , 2023
Link: https://doi.org/10.1016/..
 
?
9

POSTER: ALL-142 Efficacy and Safety of Single-Agent Blinatu..:

Açar, İbrahim Halil ; Güvenç, Birol
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S150 , 2023
Link: https://doi.org/10.1016/..
 
?
10

MM-244 Efficacy of Bendumustine, Pomalidomide, and Dexameth..:

Açar, İbrahim Halil ; Güvenç, Birol
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S483 , 2023
Link: https://doi.org/10.1016/..
 
?
11

POSTER: MDS-143 Characteristics and Outcomes of Myelodyspla..:

Açar, İbrahim Halil ; Atalay, Figen ; Demirsoy, Esra Terzi...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S180 , 2023
Link: https://doi.org/10.1016/..
 
?
12

POSTER: MDS-225 The Long-Term Efficacy of Erythropoiesis-St..:

Ak, Müzeyyen Aslaner ; Gedük, Ayfer ; Açar, İbrahim Halil...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S181 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Clinical Characteristics of Patients with Aggressive System..:

Açar, Ibrahim halil ; Guvenc, Birol
International Journal of Innovative Research in Medical Science.  8 (2023)  10 - p. 431-437 , 2023
Link: https://doi.org/10.23958..
 
?
14

POSTER: MM-244 Efficacy of Bendumustine, Pomalidomide, and ..:

Açar, İbrahim Halil ; Güvenç, Birol
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S217 , 2023
Link: https://doi.org/10.1016/..
 
?
15

MDS-143 Characteristics and Outcomes of Myelodysplastic Syn..:

Açar, İbrahim Halil ; Atalay, Figen ; Demirsoy, Esra Terzi...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S354 , 2023
Link: https://doi.org/10.1016/..
 
1-15